CEO of AAIPharma and Cambridge Major Laboratories Resigns

By Supplier News - DCAT Publisher

April 9, 2014

AAIPharma, a provider of pharmaceutical analytical testing, product development and manufacturing services, and Cambridge Major Laboratories, a provider of API development and manufacturing services, announce the resignation of Patrick Walsh as chief executive officer together with the appointment of interim CEO, Susan Nestegard.

Mr. Walsh joined AAIPharma Services Corp. in 2010 as chief executive officer. Since that time, he has led the organization through a number of successful transformational changes, including the 2013 transaction with American Capital, Ltd, in which AAIPharma and Cambridge Major Laboratories combined.

"Now that the initial foundation, leadership team and process initiatives have been identified, it is time for me to step down," stated Walsh, in  a company statement. "Over the last 6 months, I was asked to shepherd the two organizations through the first phase of the integration process," added Walsh

A current member of the companies' boards of directors, Ms. Nestegard brings over 30 years' experience in healthcare and research and development.  Ms. Nestegard is the former executive vice-president and president, global healthcare, of Ecolab Inc. She also serves on the boards of directors of American Capital, Ltd. and Hormel Foods Corporation.

Source: AAIPharma and Cambridge Major Laboratories